权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

Structural insights into pandemic and emerging influenza viruses

对大流行和新出现的流感病毒的结构见解

基本信息

批准号：
8644586
负责人：
IAN A WILSON
金额：
$ 82.26万
依托单位：
SCRIPPS RESEARCH INSTITUTE, THE
依托单位国家：
美国
项目类别：
财政年份：
2013
资助国家：
美国
起止时间：
2013-04-15 至 2015-03-31
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/8644586
关键词：
Affect Amino Acids Animals Antibodies Binding Biochemical Birds Cells Centers for Disease Control and Prevention (U.S.)Chiroptera Collaborations Complement Complex Crystallography DNA-Directed RNA Polymerase Development Disease Progression Economic Burden Electron Microscopy Epidemic Epitopes Equilibrium Event Evolution Exhibits Family suidae Future Genetic Polymorphism Genetic Transcription H7N7 Head Hemagglutinin Human Immune response Immune system Infection Influenza Influenza A Virus, H1N1 Subtype Influenza A Virus, H5N1 Subtype Influenza A virus Investigation Knowledge Laboratories Lead Mediating Membrane Glycoproteins Methodology Molecular Mutation Neuraminidase Nucleoproteins Pathogenesis Pathogenicity Phylogenetic Analysis Polymerase Polysaccharides Population RNA RNA chemical synthesis Reagent Research Ribonucleoproteins Ruthenium Ben Serotyping Site Specificity Structure Substrate Specificity Surface Antigens Technology Testing Therapeutic Intervention Tropism Vaccination Vaccines Viral Viral Genome Virulence Virulence Factors Virus Virus Diseases Virus Receptors base combat combinatorial design flu immunogenicity influenzavirus inhibitor/antagonist insight neutralizing antibody new technology novel novel strategies novel therapeutics novel vaccines pandemic disease pandemic influenza prevent receptor receptor binding response scaffold seasonal influenza small molecule stem swine flu vaccine candidate virus development

项目摘要

DESCRIPTION (provided by applicant): Influenza A viruses exhibit extreme diversity via multiple serotypes of the hemagglutinin (HA 1-16) and neuraminidase (NA 1-9) surface antigens. To date, only three of the possible 144 combinations found in bird and animal reservoirs have been associated with human pandemics (H1N1, H2N2, H3N2). Recently, a distinct lineage of influenza A viruses has been identified in bats, further increasing the spectrum of possible zoonotic viruses that could infect humans. This proposal seeks to elucidate at the structural level, key sites of vulnerability on influenza virus for development ofa sustainable cross-serotype immune response, and understand activity relationships of the surface glycoproteins (HA, NA) and ribonucleoprotein (RNP) complex, including the polymerase (PA, PB1, PB2), that underlie the pathogenicity and transmissibility of pandemic and seasonal influenza viruses. Antibody-mediated neutralization of influenza virus is a complex combinatorial problem for the human immune system as it is presented with diverse, highly variable and constantly evolving viruses. While neutralizing antibodies against human flu are traditionally regarded as being strain specific, recent studies have shown that a much broader response can be mounted over decades of evolution of a particular subtype (e.g. H3N2), across group 1 or group 2, and even across two major phylogenetic groups (I and 2). While these examples provide compelling evidence that the immune system is capable of mounting a sustained, cross-serotype response against influenza, how to elicit broadly neutralizing antibodies by vaccination is poorly understood. Therefore, we propose to determine the structural basis of broad neutralization and delineate the sites of vulnerability on the HA to enable development of novel vaccine scaffolds and even small molecule inhibitors that ameliorate or prevent disease progression. Furthermore, because we do not understand why certain viruses, such as the recent H1N1 2009 swine flu, are able to enter the human population and cause pandemics, we will also study the molecular basis of pathogenicity. Using a novel strategy to investigate both HA and NA substrate specificity and activity using newly designed glycan microarrays, we will assess the functional relationships between NA and HA activity. In this way, we will test the hypothesis that efficient infection of humans by influenza viruses requires a functional balance between the binding and specificity of HA and enzymatic activity of the NA with host glycan receptors. Another key factor in host-specific pathogenicity is the replication machinery composed of the RNP with associated polymerase, where mutations can alter polymerase activity and interaction with host cell factors. Structural and functional understanding of the RNP will enable other approaches to combat influenza infection. A combined biophysical and biochemical approach from three laboratories employing state of the art x-ray crystallography, electron microscopy and glycan array technologies will be used to provide key insights into influenza virus neutralization, tropism and pathogenesis, to reveal novel strategies to control and combat future pandemics.

性状（由申请方提供）：甲型流感病毒通过血凝素（HA 1-16）和神经氨酸酶（NA 1-9）表面抗原的多种血清型表现出极大的多样性。迄今为止，在鸟类和动物宿主中发现的可能的144种组合中，只有3种与人类流行病（H1N1、H2 N2、H3 N2）有关。最近，在蝙蝠中发现了一个独特的甲型流感病毒谱系，进一步增加了可能感染人类的人畜共患病毒的谱。该提案旨在从结构水平阐明流感病毒的关键脆弱位点，以发展可持续的跨血清型免疫应答，并了解表面糖蛋白（HA，NA）和核糖核蛋白（RNP）复合物（包括聚合酶（PA，PB 1，PB 2））的活性关系，这些活性关系是大流行性和季节性流感病毒致病性和传播性的基础。抗体介导的流感病毒中和是人类免疫系统的一个复杂的组合问题，因为它存在多种多样、高度可变和不断进化的病毒。虽然针对人类流感的中和抗体传统上被认为是菌株特异性的，但最近的研究表明，在特定亚型（例如H3 N2）的数十年进化中，可以跨越组1或组2，甚至跨越两个主要的系统发育组（I和2）建立更广泛的反应。虽然这些例子提供了令人信服的证据，表明免疫系统能够对流感产生持续的、跨血清型的应答，但人们对如何通过疫苗接种引发广泛的中和抗体知之甚少。因此，我们建议确定广泛中和的结构基础，并描绘HA上的脆弱性位点，以开发新型疫苗支架，甚至是改善或预防疾病进展的小分子抑制剂。此外，由于我们不明白为什么某些病毒，如最近的H1N1 2009猪流感，能够进入人群并引起大流行，我们还将研究致病性的分子基础。使用新设计的聚糖微阵列，使用一种新策略来研究HA和NA底物特异性和活性，我们将评估NA和HA活性之间的功能关系。通过这种方式，我们将测试流感病毒有效感染人类需要HA的结合和特异性与NA与宿主聚糖受体的酶活性之间的功能平衡的假设。宿主特异性致病性的另一个关键因素是由RNP和相关聚合酶组成的复制机制，其中突变可以改变聚合酶活性和与宿主细胞因子的相互作用。RNP的结构和功能理解将使其他方法能够对抗流感感染。三个实验室采用最先进的X射线晶体学，电子显微镜和聚糖阵列技术的生物物理和生物化学方法将用于提供流感病毒中和，嗜性和发病机制的关键见解，以揭示控制和对抗未来大流行病的新策略。